News/ News/ Oncology Lilly’s Cyramza closer to first-line lung cancer use after ODAC verdict Phil Taylor Cyramza, Eli Lilly, fda, Non-small cell lung cancer 0 Comment Eli Lilly’s cancer drug Cyramza has inched closer to a new indication in first-line non-small cell lung cancer Share X Lilly’s Cyramza closer to first-line lung cancer use after ODAC verdict https://pharmaphorum.com/news/lilly-closes-on-first-line-lung-cancer-use-after-odac-verdict/
News/ Sales and Marketing/ US New drugs boost Eli Lilly, ahead of animal health IPO Piotr Wnuk Cyramza, Eli Lilly 0 Comment Eli Lilly closed the second quarter with substantial revenue increase thanks to a strong performance from a group Share X New drugs boost Eli Lilly, ahead of animal health IPO https://pharmaphorum.com/news/lilly-charges-revenue-increase/
Cyramza, Eli Lilly, fda, Non-small cell lung cancer
0 Comment
